003020 立方制药
已收盘 07-17 15:00:00
资讯
新帖
简况
异动快报:立方制药(003020)7月17日10点58分触及跌停板
证券之星 · 07-17 11:05
异动快报:立方制药(003020)7月17日10点58分触及跌停板
异动快报:立方制药(003020)7月16日9点39分触及跌停板
证券之星 · 07-16 09:41
异动快报:立方制药(003020)7月16日9点39分触及跌停板
7月15日立方制药(003020)龙虎榜数据:北向资金净买入352.17万元
证券之星 · 07-15
7月15日立方制药(003020)龙虎榜数据:北向资金净买入352.17万元
7月15日立方制药涨5.34%,兴业医疗保健混合A基金重仓该股
证券之星 · 07-15
7月15日立方制药涨5.34%,兴业医疗保健混合A基金重仓该股
7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板
中金财经 · 07-13
7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板
异动快报:立方制药(003020)7月13日9点34分触及涨停板
证券之星 · 07-13
异动快报:立方制药(003020)7月13日9点34分触及涨停板
7月10日立方制药(003020)龙虎榜数据:机构净买入1663.54万元(3日),北向资金净卖出390.53万元(3日)
证券之星 · 07-10
7月10日立方制药(003020)龙虎榜数据:机构净买入1663.54万元(3日),北向资金净卖出390.53万元(3日)
7月10日立方制药涨9.98%,兴业医疗保健混合A基金重仓该股
证券之星 · 07-10
7月10日立方制药涨9.98%,兴业医疗保健混合A基金重仓该股
异动快报:立方制药(003020)7月9日10点18分触及涨停板
证券之星 · 07-09
异动快报:立方制药(003020)7月9日10点18分触及涨停板
7月1日立方制药涨9.12%,兴业医疗保健混合A基金重仓该股
证券之星 · 07-01
7月1日立方制药涨9.12%,兴业医疗保健混合A基金重仓该股
立方制药最新公告:举办股东感恩回馈活动提供专属优惠价产品礼包
证券之星 · 06-02
立方制药最新公告:举办股东感恩回馈活动提供专属优惠价产品礼包
股市必读:立方制药(003020)今年截至5月27日累计跌幅已超20%
证券之星 · 05-28
股市必读:立方制药(003020)今年截至5月27日累计跌幅已超20%
立方制药最新公告:取得美阿沙坦钾片药品注册证书
证券之星 · 05-22
立方制药最新公告:取得美阿沙坦钾片药品注册证书
立方制药(003020)披露2025年年度股东会决议公告,5月19日股价上涨1.32%
证券之星 · 05-19
立方制药(003020)披露2025年年度股东会决议公告,5月19日股价上涨1.32%
股市必读:立方制药(003020)5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读:立方制药(003020)5月8日披露最新机构调研信息
每周股票复盘:立方制药(003020)2025年归母净利润1.65亿元
证券之星 · 05-03
每周股票复盘:立方制药(003020)2025年归母净利润1.65亿元
股市必读:立方制药年报 - 第四季度单季净利润同比增长6.33%
证券之星 · 04-29
股市必读:立方制药年报 - 第四季度单季净利润同比增长6.33%
立方制药(003020)披露2026年一季度报告,4月27日股价下跌0.98%
证券之星 · 04-27
立方制药(003020)披露2026年一季度报告,4月27日股价下跌0.98%
图解立方制药一季报:第一季度单季净利润同比下降7.74%
证券之星 · 04-27
图解立方制药一季报:第一季度单季净利润同比下降7.74%
股市必读:立方制药(003020)3月23日收盘跌5.37%,主力净流出347.34万元
证券之星 · 03-24
股市必读:立方制药(003020)3月23日收盘跌5.37%,主力净流出347.34万元
加载更多
公司概况
公司名称:
合肥立方制药股份有限公司
所属行业:
批发业
上市日期:
2020-12-15
主营业务:
合肥立方制药股份有限公司的主营业务是药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。公司的主要产品是硝苯地平控释片、非洛地平缓释片、甲磺酸多沙唑嗪缓释片(国内首仿)、盐酸曲美他嗪缓释片、葛酮通络胶囊(独家品种)、盐酸羟考酮缓释片(10mg、40mg)、盐酸哌甲酯缓释片(国内首仿)、帕利哌酮缓释片、盐酸文拉法辛缓释片、益气和胃胶囊(独家品种)、虎地肠溶胶囊(独家品种)、亮菌口服溶液、金珍滴眼液(独家品种)、加替沙星滴眼液、吡嘧司特钾滴眼液、苄达赖氨酸滴眼液、马来酸噻吗洛尔滴眼液、盐酸丙美卡因滴眼液、丹皮酚软膏、克痤隐酮凝胶(独家品种)、复方土荆皮凝胶(独家品种)、尿素维E乳膏、坤宁颗粒、二甲双胍格列吡嗪片、伊曲康唑口服液(国内首仿)。公司两次荣获“中国医药工业最具投资价值企业”称号,连续八年入选“中国化学制药工业企业综合实力百强”,获国家高新技术企业、安徽省专精特新企业50强、安徽省科学技术奖一等奖、皖美品牌示范企业等荣誉,建有安徽省博士后科研工作站、安徽省认定企业技术中心、安徽省药物缓释工程技术中心,为安徽省医药行业协会理事长单位、合肥高新区上市企业协会会长单位,“立方”商标为中国驰名商标。
发行价格:
23.13
{"stockData":{"symbol":"003020","market":"SZ","secType":"STK","nameCN":"立方制药","latestPrice":17.75,"timestamp":1784271831000,"preClose":19.72,"halted":0,"volume":21282490,"delay":0,"changeRate":-0.0999,"floatShares":169000000,"shares":227999999,"eps":0.7109,"marketStatus":"已收盘","change":-1.97,"latestTime":"07-17 15:00:00","open":18.7,"high":18.97,"low":17.75,"amount":383000000,"amplitude":0.0619,"askPrice":17.75,"askSize":29267,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.7109,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":5,"adr":0,"adjPreClose":19.72,"symbolType":"stock","openAndCloseTimeList":[[1784251800000,1784259000000],[1784264400000,1784271600000]],"highLimit":21.69,"lowLimit":17.75,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":228218618,"isCdr":false,"pbRate":2.44,"roa":"--","peRate":24.96835,"roe":"1.93%","epsLYR":0.87,"committee":0,"marketValue":4051000000,"turnoverRate":0.1263,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-07-20。","floatMarketCap":2992000000},"requestUrl":"/m/hq/s/003020","defaultTab":"news","newsList":[{"id":"2652927479","title":"异动快报:立方制药(003020)7月17日10点58分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2652927479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652927479?lang=zh_cn&edition=full","pubTime":"2026-07-17 11:05","pubTimestamp":1784257524,"startTime":"0","endTime":"0","summary":"证券之星7月17日盘中消息,10点58分立方制药(003020)触及跌停板。其所属行业化学制药目前下跌。领涨股为哈药股份。该股为医药商业,中药,脑科学概念热股。7月16日的资金流向数据方面,主力资金净流出7281.19万元,占总成交额9.31%,游资资金净流入2146.74万元,占总成交额2.74%,散户资金净流入5134.45万元,占总成交额6.56%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700015454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651497569","title":"异动快报:立方制药(003020)7月16日9点39分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651497569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651497569?lang=zh_cn&edition=full","pubTime":"2026-07-16 09:41","pubTimestamp":1784166075,"startTime":"0","endTime":"0","summary":"证券之星7月16日盘中消息,9点39分立方制药(003020)触及跌停板。其所属行业化学制药目前下跌。领涨股为海创药业。该股为医药商业,医药,中药概念热股。7月15日的资金流向数据方面,主力资金净流入369.37万元,占总成交额0.38%,游资资金净流入1588.86万元,占总成交额1.64%,散户资金净流出1958.23万元,占总成交额2.02%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600008199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651745988","title":"7月15日立方制药(003020)龙虎榜数据:北向资金净买入352.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651745988","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651745988?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:28","pubTimestamp":1784107690,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月15日公布的交易公开信息显示,立方制药因日振幅值达到15%的前5只证券,日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年7月15日收盘,立方制药报收于21.91元,上涨5.34%,换手率27.48%,成交量46.31万手,成交额9.71亿元。从龙虎榜公布的当日买卖数据来看,北向资金合计净买入352.17万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453718","title":"7月15日立方制药涨5.34%,兴业医疗保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651453718?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:32","pubTimestamp":1784104359,"startTime":"0","endTime":"0","summary":"证券之星消息,7月15日立方制药涨5.34%,收盘报21.91元,换手率27.48%,成交量46.31万手,成交额9.71亿元。重仓立方制药的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为兴业基金的兴业医疗保健混合A。兴业医疗保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651990711","title":"7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651990711","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651990711?lang=zh_cn&edition=full","pubTime":"2026-07-13 15:32","pubTimestamp":1783927926,"startTime":"0","endTime":"0","summary":"7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板 分时图\r\n\r\n 沪指低开低走跌超2%、创业板指跌逾3%,算力硬件概念持续走弱,全市场逾百股跌停。国华退、立方制药、贵绳股份、亚联机械3连板,一图看懂>>","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/13/20260713686105.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/13/20260713686105.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260713/32305671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0086","399300","003020","BK0251","600992","001395","159982","BK0256","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162528","title":"异动快报:立方制药(003020)7月13日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651162528?lang=zh_cn&edition=full","pubTime":"2026-07-13 09:41","pubTimestamp":1783906880,"startTime":"0","endTime":"0","summary":"证券之星7月13日盘中消息,9点34分立方制药(003020)触及涨停板。其所属行业化学制药目前下跌。领涨股为立方制药。该股为中药,医药商业,医药概念热股,当日中药概念上涨0.46%,医药商业概念上涨0.16%。7月10日的资金流向数据方面,主力资金净流入4638.66万元,占总成交额14.3%,游资资金净流出722.44万元,占总成交额2.23%,散户资金净流出3916.22万元,占总成交额12.07%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300004301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650186212","title":"7月10日立方制药(003020)龙虎榜数据:机构净买入1663.54万元(3日),北向资金净卖出390.53万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650186212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650186212?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:28","pubTimestamp":1783675681,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月10日公布的交易公开信息显示,立方制药因连续三个交易日内,涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月10日收盘,立方制药报收于18.74元,上涨9.98%,已连续涨停2天,换手率10.58%,成交量17.84万手,成交额3.24亿元。从龙虎榜公布的三日买卖数据来看,机构合计净买入1663.54万元,北向资金合计净卖出390.53万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000031578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650424183","title":"7月10日立方制药涨9.98%,兴业医疗保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650424183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650424183?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:32","pubTimestamp":1783672338,"startTime":"0","endTime":"0","summary":"证券之星消息,7月10日立方制药涨9.98%,收盘报18.74元,换手率10.58%,成交量17.84万手,成交额3.24亿元。重仓立方制药的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为兴业基金的兴业医疗保健混合A。兴业医疗保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650910128","title":"异动快报:立方制药(003020)7月9日10点18分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2650910128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650910128?lang=zh_cn&edition=full","pubTime":"2026-07-09 10:25","pubTimestamp":1783563923,"startTime":"0","endTime":"0","summary":"证券之星7月9日盘中消息,10点18分立方制药(003020)触及涨停板。其所属行业化学制药目前上涨。领涨股为立方制药。该股为脑科学,眼科,医药概念热股,当日脑科学概念上涨0.55%,眼科概念上涨0.16%。7月8日的资金流向数据方面,主力资金净流出335.74万元,占总成交额5.44%,游资资金净流入384.3万元,占总成交额6.23%,散户资金净流出48.56万元,占总成交额0.79%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900012259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648516601","title":"7月1日立方制药涨9.12%,兴业医疗保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648516601?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:50","pubTimestamp":1782895801,"startTime":"0","endTime":"0","summary":"证券之星消息,7月1日立方制药涨9.12%,收盘报16.16元,换手率4.61%,成交量7.77万手,成交额1.23亿元。重仓立方制药的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为兴业基金的兴业医疗保健混合A。兴业医疗保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640919992","title":"立方制药最新公告:举办股东感恩回馈活动提供专属优惠价产品礼包","url":"https://stock-news.laohu8.com/highlight/detail?id=2640919992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640919992?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:23","pubTimestamp":1780392197,"startTime":"0","endTime":"0","summary":"立方制药(003020.SZ)公告称,公司为答谢股东支持,将举办“股东感恩回馈活动”。2026年5月28日收市后登记在册的全体股东,可在公告发布之日起至2026年6月25日期间,以专属优惠价购买指定产品礼包1份,礼包包含丹皮酚软膏5盒,数量上限为15000份,先到先得。本次活动不属于利润分配,不会对公司经营产生重大影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200033085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638751638","title":"股市必读:立方制药(003020)今年截至5月27日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638751638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638751638?lang=zh_cn&edition=full","pubTime":"2026-05-28 02:55","pubTimestamp":1779908110,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘,立方制药报收于19.81元,下跌2.17%,换手率1.55%,成交量2.18万手,成交额4305.31万元。交易信息汇总股价提醒5月27日立方制药收盘报19.81元,跌2.17%,当日成交218.06万元。该股已连续3日下跌,当年累计跌幅20.23%。前10个交易日主力资金累计净流出3082.11万元,期间股价累计下跌9.59%。资金流向5月27日主力资金净流出307.73万元;游资资金净流入412.5万元;散户资金净流出104.78万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800001915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637313076","title":"立方制药最新公告:取得美阿沙坦钾片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2637313076","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637313076?lang=zh_cn&edition=full","pubTime":"2026-05-22 18:31","pubTimestamp":1779445881,"startTime":"0","endTime":"0","summary":"立方制药(003020.SZ)公告称,公司收到国家药品监督管理局核准签发的美阿沙坦钾片(40mg、80mg)《药品注册证书》。该药品适用于治疗成人原发性高血压,将进一步丰富公司产品管线,增强原料、制剂一体化产业链优势,提升市场竞争力。以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200036845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636837886","title":"立方制药(003020)披露2025年年度股东会决议公告,5月19日股价上涨1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636837886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636837886?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:00","pubTimestamp":1779184847,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,立方制药报收于21.49元,较前一交易日上涨1.32%,最新总市值为40.87亿元。该股当日开盘21.29元,最高21.69元,最低21.23元,成交额达2815.92万元,换手率为0.95%。公司于近日披露《2025年年度股东会决议公告》。公告显示,合肥立方制药股份有限公司于2026年5月18日召开2025年年度股东会,会议由董事会召集,董事长季俊虬主持,采用现场与网络投票结合方式召开。出席会议的股东及代理人共115名,代表股份123,931,636股,占公司有表决权股份总数的65.1647%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634296464","title":"股市必读:立方制药(003020)5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634296464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634296464?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:03","pubTimestamp":1778443396,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,立方制药报收于23.21元,上涨0.69%,换手率0.89%,成交量1.22万手,成交额2805.01万元。截至2026年4月底,立优加已在全国绝大部分省份实现销售,累计入院近200家,麻精生产线使用率目前尚不饱和。诺瑞特目前处于新产品研发阶段,布局纳米晶长效注射、小容量注射液和眼科用药,2025年完成1个新产品注册申报,预计2026年将有四款产品报产,包括一款优先审评的短缺产品。2025年研发费用同比增长21%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608385","title":"每周股票复盘:立方制药(003020)2025年归母净利润1.65亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608385","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608385?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:56","pubTimestamp":1777766168,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,立方制药报收于22.73元,较上周的23.52元下跌3.36%。股本股东变化截至2026年3月31日,立方制药股东户数为1.66万户,较2025年12月31日减少238.0户,减幅1.41%。业绩披露要点立方制药2025年实现主营收入15.54亿元,同比增长2.33%;归母净利润1.65亿元,同比增长2.86%;扣非净利润1.26亿元,同比下降15.78%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631553097","title":"股市必读:立方制药年报 - 第四季度单季净利润同比增长6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553097","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631553097?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:28","pubTimestamp":1777418918,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年一季度报告立方制药2026年第一季度实现营业收入357,096,223.21元,同比下降0.87%;归属于上市公司股东的净利润为35,290,847.30元,同比下降7.74%;扣除非经常性损益后的净利润为33,510,313.12元,同比增长6.04%。关于2025年度利润分配及资本公积金转增股本预案的公告合肥立方制药股份有限公司于2026年4月24日召开第六届董事会第五次会议,审议通过《2025年度利润分配及资本公积金转增股本预案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900022357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630139024","title":"立方制药(003020)披露2026年一季度报告,4月27日股价下跌0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630139024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630139024?lang=zh_cn&edition=full","pubTime":"2026-04-27 22:18","pubTimestamp":1777299510,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,立方制药报收于23.29元,较前一交易日下跌0.98%,最新总市值为44.29亿元。该股当日开盘23.49元,最高23.57元,最低23.22元,成交额达3495.58万元,换手率为1.09%。近日,立方制药披露《2026年第一季度报告》。报告显示,公司2026年第一季度实现营业收入357,096,223.21元,同比下降0.87%;归属于上市公司股东的净利润为35,290,847.30元,同比下降7.74%;扣除非经常性损益后的净利润为33,510,313.12元,同比增长6.04%。基本每股收益为0.19元,同比下降5.00%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700046210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630642793","title":"图解立方制药一季报:第一季度单季净利润同比下降7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630642793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630642793?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:52","pubTimestamp":1777283521,"startTime":"0","endTime":"0","summary":"证券之星消息,立方制药2026年一季报显示,一季度公司主营收入3.57亿元,同比下降0.87%;归母净利润3529.08万元,同比下降7.74%;扣非净利润3351.03万元,同比上升6.04%;负债率25.03%,投资收益-90.68万元,财务费用18.38万元,毛利率65.86%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700032975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621819180","title":"股市必读:立方制药(003020)3月23日收盘跌5.37%,主力净流出347.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621819180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621819180?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:53","pubTimestamp":1774295587,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,立方制药报收于22.2元,下跌5.37%,换手率1.39%,成交量1.91万手,成交额4283.91万元。当日关注点来自交易信息汇总:立方制药股价连续3日下跌,3月23日收盘报22.2元,跌5.37%。资金流向3月23日主力资金净流出347.34万元;游资资金净流出103.59万元;散户资金净流入450.94万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"ret":0,"serverTime":1784396143919,"stockEarnings":[{"period":"1week","weight":-0.0528},{"period":"1month","weight":0.1739},{"period":"3month","weight":-0.1062},{"period":"6month","weight":-0.2091},{"period":"1year","weight":-0.1006},{"period":"ytd","weight":-0.1642}],"compareEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":-0.0837},{"period":"3month","weight":-0.0709},{"period":"6month","weight":-0.0823},{"period":"1year","weight":0.0703},{"period":"ytd","weight":-0.0516}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"合肥立方制药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"16639人(较上一季度减少89.24%)","perCapita":"10129股","listingDate":"2020-12-15","address":"安徽省合肥市蜀山区长江西路669号立方厂区","registeredCapital":"22821万元","survey":" 合肥立方制药股份有限公司的主营业务是药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。公司的主要产品是硝苯地平控释片、非洛地平缓释片、甲磺酸多沙唑嗪缓释片(国内首仿)、盐酸曲美他嗪缓释片、葛酮通络胶囊(独家品种)、盐酸羟考酮缓释片(10mg、40mg)、盐酸哌甲酯缓释片(国内首仿)、帕利哌酮缓释片、盐酸文拉法辛缓释片、益气和胃胶囊(独家品种)、虎地肠溶胶囊(独家品种)、亮菌口服溶液、金珍滴眼液(独家品种)、加替沙星滴眼液、吡嘧司特钾滴眼液、苄达赖氨酸滴眼液、马来酸噻吗洛尔滴眼液、盐酸丙美卡因滴眼液、丹皮酚软膏、克痤隐酮凝胶(独家品种)、复方土荆皮凝胶(独家品种)、尿素维E乳膏、坤宁颗粒、二甲双胍格列吡嗪片、伊曲康唑口服液(国内首仿)。公司两次荣获“中国医药工业最具投资价值企业”称号,连续八年入选“中国化学制药工业企业综合实力百强”,获国家高新技术企业、安徽省专精特新企业50强、安徽省科学技术奖一等奖、皖美品牌示范企业等荣誉,建有安徽省博士后科研工作站、安徽省认定企业技术中心、安徽省药物缓释工程技术中心,为安徽省医药行业协会理事长单位、合肥高新区上市企业协会会长单位,“立方”商标为中国驰名商标。","listedPrice":23.13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"立方制药,003020,立方制药股票,立方制药股票老虎,立方制药股票老虎国际,立方制药行情,立方制药股票行情,立方制药股价,立方制药股市,立方制药股票价格,立方制药股票交易,立方制药股票购买,立方制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}